Inventor
MORRA MARC R
US15 patents
⚠️ This page may combine multiple inventors who share the name “MORRA MARC R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
10 patentsUS9353176B2May 31, 2016
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA67 citations97
US7988967B2Aug 2, 2011
High affinity human antibodies to human nerve growth factor
REGENERON PHARMA39 citations95
US8637031B2Jan 28, 2014
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA16 citations92
US10266588B2Apr 23, 2019
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA4 citations83
US11518804B2Dec 6, 2022
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA0 citations62
US9028819B2May 12, 2015
Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2
REGENERON PHARMA1 citations61
US10745471B2Aug 18, 2020
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA0 citations51
US10513557B2Dec 24, 2019
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA0 citations51
US9371383B2Jun 21, 2016
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA1 citations51
US9150648B2Oct 6, 2015
Anti-ASIC1 antibodies and uses thereof
REGENERON PHARMA0 citations51
MACDONALD LYNN
5 patentsUS8309088B2Nov 13, 2012
Method of treating osteoarthritis with an antibody to NGF
MACDONALD LYNN77 citations97
US8148107B2Apr 3, 2012
High affinity human antibodies to human nerve growth factor
MACDONALD LYNN52 citations97
US8613927B2Dec 24, 2013
High affinity human antibodies to human nerve growth factor
MACDONALD LYNN20 citations92
US8425907B2Apr 23, 2013
Methods for treating pruritus by administering an antibody that specifically binds human PAR2
MACDONALD LYNN14 citations91
US8101724B2Jan 24, 2012
High-affinity human antibodies to human protease-activated receptor-2
MACDONALD LYNN10 citations82